Alcon stock holds steady as analysts reaffirm Buy ratings

Published on 09/20/2026 at 12:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Alcon stock closed at CHF 54.44 on September 17, 2026 on SIX, around 20 percent below its 52-week high of CHF 68.34. Deutsche Bank reiterated a Buy rating with a CHF 73.00 target on August 17, 2026, implying clear upside from current levels.

Black and white photojournalism style. Ophthalmologist using slit-lamp biomicroscope to examine patient seated in optometry chair, strong chiaroscuro contrast, documentary grain, intimate clinical moment captured in wide horizontal frame — Alcon CH0432492467: Schwarz Weiß Fotografie eines Augenarztes mit Spaltlampe und Patient im Untersuchungsstuhl, Illustration mit AI erstellt.

Alcon stock (ISIN CH0432492467) last traded at CHF 54.44 on the SIX Swiss Exchange on September 17, 2026, with a prior close of CHF 55.10 and a 52-week range between CHF 47.80 and CHF 68.34 per Investing.com data. This puts the current level roughly 20 percent below the 52-week high, leaving visible headroom for investors watching the eye-care specialist.

Analysts keep Alcon stock on Buy

Analyst sentiment remains constructive on Alcon stock as of mid-September 2026. According to Investing.com on September 17, 2026, Deutsche Bank maintains a Buy recommendation on Alcon with a price target of CHF 73.00, compared with a previous target of CHF 70.00 set earlier. At the current share price of CHF 54.44, Deutsche Bank’s target implies potential upside of roughly 34 percent, underlining the bank’s confidence in the company’s medium-term growth.

The same analyst overview compiled by Investing.com reports that the average 12-month price target for Alcon stands at CHF 75.40 as of September 17, 2026, with high and low estimates of CHF 86.86 and CHF 48.88 respectively. Based on this consensus, the stock trades at a meaningful discount to the mean target, which suggests that a majority of the 22 analysts in the overview still see room for appreciation if the company delivers on its operational plans.

Valuation context and dividend expectations

Valuation metrics and forward expectations help frame the upside analysts are modeling. A separate overview for Alcon shares listed on the New York Stock Exchange compiled by Boursorama on September 19, 2026 shows a three-month price objective of USD 86.85, corresponding to an estimated upside of about 26 percent from the recent U.S. trading level.

The same forecast table on Boursorama indicates estimated net earnings per share of USD 3.45 for 2026 and USD 4.00 for 2027, up from USD 3.07 in 2025. That implies earnings growth of about 12.4 percent from 2025 to 2026 and a further 15.9 percent from 2026 to 2027 if the estimates are achieved, supporting the view that Alcon’s profitability can steadily expand over the next two years.

Dividend expectations add another layer to the investment case. The same consensus on Boursorama shows forecast dividends per share of USD 0.35 for 2026 and USD 0.40 for 2027, compared with USD 0.28 paid in 2025. On the 2026 earnings estimate, this would correspond to a payout ratio just over 10 percent, leaving ample capacity for reinvestment while gradually improving the cash return to shareholders.

How the market is pricing Alcon today

On the Swiss primary listing, Alcon’s share price of CHF 54.44 on September 17, 2026 is near the lower half of its 52-week band of CHF 47.80 to CHF 68.34 recorded by Investing.com. Relative to the 52-week low, the current level is about 14 percent higher, while it sits roughly 20 percent below the 52-week high, suggesting that the stock has not yet fully retraced earlier strength.

Daily trading data from Investing.com also show that on September 17, 2026 the intraday range for Alcon shares was CHF 54.32 to CHF 55.00, a relatively narrow band that points to contained volatility on that day. For investors, such trading patterns can matter: a tight range amid positive analyst targets may indicate a consolidation phase in which market participants are assessing the next catalyst.

Stock perspective for investors

From an investor’s point of view, the combination of a CHF 54.44 share price as of September 17, 2026, a consensus 12-month target of CHF 75.40, and individual calls such as Deutsche Bank’s CHF 73.00 Buy rating suggests that Alcon stock is currently priced with a margin to the fundamental outlook expected by the analyst community. If Alcon’s actual reported results in 2026 and 2027 track the estimated earnings growth from USD 3.07 in 2025 to USD 3.45 and USD 4.00 respectively, the current valuation could prove attractive in hindsight.

At the same time, investors need to weigh potential risks that could challenge these forecasts, including execution on product launches, competitive dynamics in eye care devices and surgical instruments, and currency movements affecting both Swiss-franc and U.S.-dollar denominated earnings. The relatively modest forecast dividend yield, rising from about 0.42 percent in 2025 to an estimated 0.52 percent in 2026 and 0.60 percent in 2027 according to Boursorama, also underlines that the stock is primarily a growth and quality play rather than a high-income name.

Alcon stock on SIX Swiss Exchange

As of the last completed trading day documented in the available data, Alcon stock closed at CHF 54.44 on the SIX Swiss Exchange on September 17, 2026, with a prior close of CHF 55.10 and an intraday range of CHF 54.32 to CHF 55.00. The 52-week range from CHF 47.80 to CHF 68.34 and the analyst targets clustered between CHF 73.00 and CHF 86.85 frame the debate about whether the current price leaves sufficient upside for new buyers.